HomeNewsBusinessWill find it difficult to maintain profit margin going forward: RITES CMD Rahul Mithal

Will find it difficult to maintain profit margin going forward: RITES CMD Rahul Mithal

Rites will find it tough to maintain its operating margin at around 25 percent as the company was unable to win any new high-margin export orders during the pandemic. However, it is aggressively pitching for new export orders in Bangladesh, Sri Lanka, and Mozambique.

November 21, 2022 / 17:35 IST
Story continues below Advertisement
(Representative image)
(Representative image)

Rites (formerly known as Rail India Technical & Economic Service) will struggle to maintain its high operating profit margin in the upcoming quarters due to a fall in export orders, the company’s CMD Rahul Mithal told Moneycontrol in an interview.

Mithal said that while the company will try to maintain its operating profit margin at around 25 percent in the coming quarter, a combination of rising commodity prices and falling orders in the high-margin export segment will make things difficult.

Story continues below Advertisement

He added that the fall in export orders seen in the last two quarters is likely to continue for another 2-3 quarters as the company was unable to win new orders during the pandemic.

Mithal also said that Rites has aggressively started bidding for new export orders in Bangladesh, Sri Lanka, and Mozambique in order to reverse the matter of falling orders.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show